HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

lestaurtinib

structure in first source; indolocarbazole; used in treatment of acute myeloid leukemia
Also Known As:
CEP 701; CEP-701; CEP701; KT-5555; KT5555
Networked: 40 relevant articles (5 outcomes, 13 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Levis, Mark: 7 articles (03/2011 - 05/2004)
2. Small, Donald: 7 articles (03/2011 - 05/2004)
3. Smith, B Douglas: 5 articles (03/2011 - 05/2004)
4. Brodeur, Garrett M: 3 articles (12/2011 - 03/2010)
5. Minturn, Jane E: 3 articles (12/2011 - 03/2010)
6. Maris, John M: 3 articles (12/2011 - 03/2010)
7. Sato, Takashi: 3 articles (03/2011 - 02/2010)
8. Denmeade, Samuel R: 3 articles (09/2007 - 02/2002)
9. Baer, Maria R: 2 articles (09/2015 - 03/2011)
10. Hexner, Elizabeth O: 2 articles (09/2015 - 06/2008)

Related Diseases

1. Neoplasms (Cancer)
2. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
3. Prostatic Neoplasms (Prostate Cancer)
4. Neuroblastoma
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. lestaurtinib
2. Phosphotransferases (Kinase)
3. tyrosine receptor (receptor, tyrosine)
4. Brain-Derived Neurotrophic Factor (BDNF)
5. bicalutamide (Casodex)
6. K 252 (K252a)
7. Protein-Tyrosine Kinases (Tyrosine Kinase)
8. Tyrosine (L-Tyrosine)
9. PKC412
10. Staurosporine

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Heterologous Transplantation (Xenotransplantation)
3. Stents